CN Patent

CN101326182B — 2-嘧啶基吡唑并吡啶ErbB激酶抑制剂

Assigned to SmithKline Beecham Corp · Expires 2011-09-28 · 15y expired

What this patent protects

本发明提供2-嘧啶基吡唑并吡啶化合物，包含所述化合物的组合物，以及它们的制备方法和它们用作药物的用途。

USPTO Abstract

本发明提供2-嘧啶基吡唑并吡啶化合物，包含所述化合物的组合物，以及它们的制备方法和它们用作药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101326182B
Jurisdiction
CN
Classification
—
Expires
2011-09-28
Drug substance claim
No
Drug product claim
No
Assignee
SmithKline Beecham Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.